Erlotinib is a BCS (biopharmaceutical classification system) class II drug used for the
treatment of non-small cell lung cancer. There is an urgent need to obtain new solid forms of …

Erlotinib, a non-small cell lung cancer BCS class II drug, was found to occur as two
polymorphs and two hydrates depending on the crystallization conditions. The monohydrate …

Erlotinib [systematic name: N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy) quinazolin-4-
amine], a small-molecule epidermal growth factor receptor inhibitor, useful for the treatment …

Erlotinib hydrochloride (EtbHCl), whose polymorphism is still ill-characterized, is an
essential component of the current armamentarium for the treatment of pancreatic and lung …

In the cation of the title compound, C22H24N3O4+· Cl−, an active ingredient of the
anticancer drug also known as Tarceva, the quinazoline ring system is planar within 0.044 …

Gefitinib or Iressa is an orally administered anilinoquinazoline used in cancer chemotherapy
for the treatment of lung and breast cancer. It is reported to exist in two polymorphic forms, a …

The objectives of the study were to screen and prepare cocrystals of anti-cholesterol drug
ezetimibe (EZT) with the aim of increasing its solubility and dissolution rate. Thermodynamic …

Multidrug crystals, comprising multiple drugs in the same crystal lattice, can be used to
develop drug combinations with improved physicochemical properties. The investigation on …

Pharmaceutical cocrystals involving an analgesic drug, ethenzamide (EA) and coformers,
such as salicylic acid (SA), 2-chloro-4-nitrobenzoic acid (CNBA), vanillic acid (VA), 4 …

Ethenzamide is a small, conformationally labile pharmaceutical molecule which crystallizes
in an unusual conformation relative to both its co-crystals and to similar molecules found in …